clinical trials
-
Research updates, November 26
-
Still Here, November 22: Links and transcript
This week, reporter Simon Spichak talks about his coverage of the lack of pediatric clinical trials for Long COVID. Also in this episode: the latest COVID-19 numbers, results from the BC 007 clinical trial, and REVERSE-LC begins recruitment.
-
RECOVER-TLC is moving toward new clinical trials, initiative leaders share in webinar
In a webinar on Thursday, leaders from the National Institute of Allergy and Infectious Diseases (NIAID) and Foundation for the National Institutes of Health (FNIH) shared updates from RECOVER-Treating Long COVID (RECOVER-TLC), an initiative that will launch new clinical trials to study Long COVID. Speakers discussed early results from an online portal in which Long…
-
Why are there almost no clinical trials for kids with Long COVID?
Experts who spoke with The Sick Times brought up many different reasons why developing new drugs for children with Long COVID has moved at such a glacial pace. Many pharmaceutical companies might not see Long COVID as profitable. And running trials in children is complex and expensive, as they can have different symptoms and underlying…
-
Research updates, November 19
-
Still Here, November 15: Links and transcript
This week, we celebrate one year of The Sick Times! Also in this episode: the latest COVID-19 numbers, and recapping the team’s coverage of the Fall 2024 PolyBio Symposium on Long COVID Research.
-
Research updates, November 12
-
Still Here, November 10: Links and transcript
This week, oral histories from mask bloc organizers are interspersed with some context from journalist and author Britta Shoot, who put together a three-part series collaging said oral histories.
-
Live blog: Following the Fall 2024 PolyBio Symposium on Long COVID research
On Friday, a number of prominent Long COVID scientists are set to present updates on their work at the PolyBio Research Foundation’s fall research symposium. PolyBio is a leading organization in supporting formative Long COVID science; it has backed research into Long COVID’s biological causes as well as clinical trials aiming to address those underlying…
-
Research updates, November 5
*Editor’s note: The PolyBio Research Foundation, like The Sick Times, has received support from the Balvi and Kanro funds. Our newsroom operates independently of financial supporters.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance